A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG

Clinical trial NCT05123534 · SUSPENDED

Trial details

NCT number: NCT05123534
Sponsor: SonALAsense, Inc.
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma Diffuse Midline Glioma

Start date: 2022-08-12
Primary completion: 2024-07-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.